سعر فوتابرامين 20مجم 30 قرص 2024

Escitalopram 20 mg film-coated tablets, 30 per pack, by Future Pharmaceutical Industries (Egypt); SSRI antidepressant.

• Major depressive disorder in adults and pediatric patients 12 years and older (US label).Population: Adults and adolescents 12 years and olderDailyMed (U.S. National Library of Medicine)
• Generalized anxiety disorder in adults and pediatric patients 7 years and older (US label).Population: Adults and children 7 years and olderDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (about 5% or more and about twice placebo): insomnia, ejaculation disorder, nausea, increased sweating, fatigue and somnolence.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Use with MAOIs or within 14 days of stopping an MAOI (or of stopping escitalopram before an MAOI), including linezolid or IV methylene blue, because of serotonin syndrome risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant pimozide; hypersensitivity to escitalopram, citalopram or any inactive ingredient.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: antidepressants increased the risk of suicidal thoughts and behaviours in pediatric and young adult patients; monitor all patients for clinical worsening and suicidality.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Serotonin syndrome (especially with other serotonergic drugs), discontinuation syndrome on abrupt stop, hyponatremia (SIADH), increased bleeding risk with aspirin/NSAIDs/anticoagulants, activation of mania, seizures and angle-closure glaucoma.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• MAOIs (including linezolid, IV methylene blue)Contraindicated combination: increased risk of serotonin syndrome.DailyMed (U.S. National Library of Medicine)
• Aspirin, NSAIDs, warfarin and other anticoagulantsMay add to the risk of bleeding.DailyMed (U.S. National Library of Medicine)

• Observational data have not established an increased risk of major birth defects or miscarriage; SSRI exposure late in pregnancy carries risks of persistent pulmonary hypertension of the newborn, poor neonatal adaptation and postpartum haemorrhage.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Escitalopram and its metabolite pass into breast milk; excessive sedation, restlessness, poor feeding and poor weight gain have been reported in exposed infants.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Escitalopram (as oxalate): Thought to enhance serotonergic activity in the CNS via inhibition of neuronal reuptake of serotonin (US Lexapro label).